why choose us

First received: November 10, 2022

Clinical Trial: The Nanowear Wearable System SimpleSense Validation Trial for Cardiac Output

Study Status: Completed

Recruit Status: RECRUITING

Condition: Right Heart Catheterization

Study Type: OBSERVATIONAL


Official Title: The Nanowear Wearable System SimpleSense Validation Trial for Cardiac Output, Cardiac Power Output and Pulmonary Artery Pressure.in Patients Undergoing Right Heart Catheterization

Brief Summary: The Nanowear SimpleSense study is a single center, prospective, non-randomized, feasibility, non- significant risk study The study will be done in 2 phases.Phase 1 will use SimpleSense data collected from the first set of subjects and associate the data from SimpleSense to the right heart catheterization values.'Phase 2 will evaluate the algorithms developed to estimate cardiac output from SimpleSense data using a second set of subjects from within the sample population that are sequestered from the first set…

Read more